Статья
2022
Hydrophilic sulfur-containing antioxidant sodium 3-(3-tert-butyl-4-hydroxyphenyl)propylthiosulfate as a modulator of the activity of antitumor cytostatics and their combinations with a NO donor
T. N. Bogatyrenko, N. V. Kandalintseva, T. E. Sashenkova, U. Yu. Allayarova, D. V. Mishchenko
Российский химический вестник
https://doi.org/10.1007/s11172-022-3442-1
Abstract / Full Text
The interaction of a combination of a sulfur-containing phenolic antioxidant sodium 3-(3-tert-butyl-4-hydroxyphenyl)propylthiosulfate (TS-13) with a nitric oxide donor (NaNO2) and two antitumor cytostatics, cisplatin and doxorubicin, was studied in vivo using a model of P-388 murine leukemia of BDF1 mice. It has been shown that the type of cytostatics used determines the efficiency of chemotherapy. Depending on this, the antioxidant TS-13 can both enhance and reduce the antitumor effect. The use of TS-13 and a nitric oxide donor with different cytostatics and different modes of drug administration modulates their activity in different ways, namely, from increasing survival to inhibition of survival.
Author information
- Institute of Problems of Chemical Physics, Russian Academy of Sciences, 1 prosp. Akad. Semenova, 142432, Chernogolovka, Moscow Region, Russian FederationT. N. Bogatyrenko, T. E. Sashenkova, U. Yu. Allayarova & D. V. Mishchenko
- Novosibirsk State Pedagogical University, 28 ul. Vilyuyskaya, 630126, Novosibirsk, Russian FederationN. V. Kandalintseva
References
- D. P. Jones, H. Sies, Antioxid. Redox Signaling, 2015, 23, 734; DOI: https://doi.org/10.1089/ars.2015.6247.
- D. B. Korman, Misheni i mekhanizmy deistviya protivoopukholevykh preparatov [Targets and Mechanisms of Action of Anticancer Drugs], Practical Medicine, Moscow, 2014, 336 pp. (in Russian).
- R. S. Kerbel, B. A. Kamen, Nat. Rev. Cancer, 2004, 4, 423; DOI: https://doi.org/10.1038/nrc1369.
- A. Gnoni, N. Silvestris, A. Licchetta, D. Santini, M. Scartozzi, R. Ria, S. Pisconti, F. Petrelli, A. Vacca, V. Lorusso, Crit. Rev. Oncol. Hematol., 2015, 95, 46; DOI: https://doi.org/10.1016/j.critrevonc.2015.01.008.
- H. Pere, C. Tanchot, J. Bayry, M. Terme, J. Taieb, C. Badoual, O. Adotevi, N. Merillon, E. Marcheteau, V. R. Quillien, C. Banissi, A. Carpentier, F. Sandoval, M. Nizard, F. Quintin-Colonna, G. Kroemer, W. H. Fridman, L. Zitvogel, S. P. Oudard, E. Tartour, Oncoimmunology, 2012, 1, 326; DOI: https://doi.org/10.4161/onci.18852.
- N. Andre, M. Carre, E. Pasquier, Nat. Rev. Clin. Oncol., 2014, 11, 413; DOI: https://doi.org/10.1038/nrclinonc.2014.89.
- A. A. Prosenko, S. Yu. Klepikova, N. V. Kandalintseva, O. I. Dyubchenko, M. I. Dushkin, N. K. Zenkov, E. B. Menshchikova, Byul. Sib. otdel. Ros. Akad. med. nauk [Bull. Sibirian Branch Russ. Acad. Med. Sci.], 2001, 21, 114 (in Russian).
- N. K. Zenkov, E. B. Menshchikova, N. V. Kandalintseva, A. S. Oleynik, A. E. Prosenko, O. N. Gusachenko, O. A. Shklyaeva, V. A. Vavilin, V. V. Lyakhovich, Biochemistry (Moscow), 2007, 72, 644; DOI: https://doi.org/10.1134/S0006297907060077.
- Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv [Guidelines for Conducting Preclinical Studies of Medicinal Products], Part 1, Ed. A. N. Mironova, Grig and K, Moscow, 2012, 944 pp. (in Russian).
- E. M. Treschalina, O. S. Zhukova, G. K. Gerasimova, N. V. Andronova, A. M. Garin, Rukovodstvo po eksperimentalnomu (doklinicheskomu) izucheniyu novykh farmakologicheskikh veshchestv: metodicheskie ukazaniya po izucheniyu protivoopukholevoi aktivnosti farmakologicheskikh vechestv [Guidelines for the Experimental (Preclinical) Study of New Pharmacological Substances: Guidelines for the Study of the Antitumor Activity of Pharmacological Substances], Meditsina, Moscow, 2005, 637 pp. (in Russian).
- Eksperimentalnaya otsenka protivoopukholevykh preparatov v SSSR i SShA [Experimental Evaluation of Anticancer Drugs in the USSR and the USA], Eds Z. P. Sofina, A. B. Syrkina, A. Goldin, A. Klein, Meditsina, Moscow, 1980, 293 pp. (in Russian).
- E. L. Kaplan, P. Meier, J. Am. Statist. Assoc., 1958, 53, 457; DOI: https://doi.org/10.2307/2281868.JSTOR2281868.
- H. S. Chung, S. B. Wang, V. Venkatraman, C. J. Murray, J. E. Van Eyk, Circ. Res., 2013, 112, 382; DOI: https://doi.org/10.1161/CIRCRESAHA.118.312789.
- J. Yang, K. S. Carroll, D. C. Liebler, Mol. Cell. Proteomics, 2016, 15, 1; DOI: https://doi.org/10.1074/mcp.O115.056051.
- T. N. Bogatyrenko, Z. V. Kuropteva, L. M. Baider, T. E. Sachenkova, D. V. Michenko, V. R. Bogatyrenko, N. P. Konovalova, Russ. Chem. Bull., 2016, 65, 561; DOI: https://doi.org/10.1007/s11172-016-1337-8.
- L. C. Godoy, C. T. M. Anderson, R. Chowdhury, L. J. Trudel, G. N. Wogan, PNAS, 2012, 109, 20373; DOI: https://doi.org/10.1073/pnas.1218938109.
- T. N. Bogatyrenko, Z. V. Kuropteva, L. M. Baider, I. V. Serkov, V. R. Bogatyrenko, T. E. Sachenkova, E. N. Klimanova, D. V. Mishchenko, N. P. Konovalova, Russ. Chem. Bull., 2016, 65, 2509; DOI: https://doi.org/10.1007/s11172-016-1615-5.
- T. N. Bogatyrenko, N. P. Konovalova, A. M. Sipyagin, V. R. Bogatyrenko, Z. V. Kuropteva, L. M. Baider, T. E. Sachenkova, B. S. Fedorov, Russ. Chem. Bull., 2014, 63, 1187; DOI: https://doi.org/10.1007/s11172-014-0570-2.
- G. G. Martinovich, I. V. Martinovich, A. V. Vcherashniaya, N. K. Zenkov, S. N. Cherenkevich, E. B. Menshchikova, N. V. Kandalintseva, Biophysics Engl. Transl., 2017, 62, 942; DOI: https://doi.org/10.1134/S000635091706015X.
- T. N. Bogatyrenko, N. V. Kandalintseva, T. E. Sashenkova, D. V. Mishchenko, Russ. Chem. Bull., 2018, 67, 700; DOI: https://doi.org/10.1007/s11172-018-2125-4.